文献速递进行纵隔淋巴结清扫纵隔淋巴结采
2021-10-2 来源:本站原创 浏览次数:次大家好,这里是集才华与美貌与性感与骚气的大胸xie!欢迎大家来到每日22点更新的文献速递环节。今天是年7月12日星期日!
今天的文献速递内容主要有:
1
进行纵隔淋巴结清扫、纵隔淋巴结采样或两者都没有进行的早期非小细胞肺癌的生存率
2
Pembrolizumab(派姆单抗)联合化疗治疗转移性鳞状非小细胞肺癌患者的随机、安慰剂对照试验:KEYNOTE-方案指定的最终分析
3
呋喹替尼(fruquintinib)在中国晚期非鳞状非小细胞肺癌患者中的III期,随机,双盲,安慰剂对照多中心研究-FALUCA研究
优秀的青年们,别忘了读文献哦~
阅读小提示:将DOI复制到scihub可以到查找全文~
1
Survivalaftermediastinalnodedissection,systematicsamplingorneitherforearly-stagenon-small-celllungcancer
进行纵隔淋巴结清扫、纵隔淋巴结采样或两者都没有进行的早期非小细胞肺癌的生存率
INTRODUCTION:
AmericanCollegeofSurgeonsOncologyGroupZfoundnosurvivaldifferencebetweenpatientswithearly-stagenon-small-celllungcancerwhohadmediastinalnodaldissectionorsystematicsampling.However,ameta-analysisof1,patientsinfiverandomizedcontrolledtrialsfrom-associatedbettersurvivalwithnodaldissection.Wetestedthesurvivalimpactoftheextentofnodaldissectionincurative-intentresectionsforearly-stagenon-smallcelllungcancerinapopulation-basedobservationalcohort.
METHODS:
ResectionsforclinicalT1orT2,N0ornon-hilarN1,M0non-small-celllungcancer,withinfourcontiguousUnitedStatesHospitalReferralRegionsfrom-werecategorizedintomediastinalnodaldissection,systematicsampling,andneither,basedonlymphnodestationsexamined.We